New Bladder Cancer Therapy Approved by FDA

Published on April 23, 2024

The U.S. health regulator approved on Monday ImmunityBio’s combination therapy to treat a type of bladder cancer, marking an end to the company’s efforts to bring its therapy to the market. The agency’s green light is a shot in the arm for ImmunityBio, which had reiterated…

Read Full Article (External Site)